Log In
Print
BCIQ
Print
Print this Print this
 

WDVAX

  Manage Alerts
Collapse Summary General Information
Company Dana-Farber Cancer Institute
DescriptionImplantable dendritic cell-activating scaffold that incorporates autologous melanoma cell lysates
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationMelanoma
Indication DetailsTreat metastatic melanoma
Regulatory Designation

Partner

Harvard University


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today